| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |